300+ investors in your industry, stage, and region Get
Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Cryptocurrency
Oil and Gas
Film
Retail
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
B2B
Blockchain
Social Network
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Art
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Recruiting
Web3
Medical
Theatre
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
South Korea
Benin
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Japan
Poland
Oman
Puerto Rico
Cameroon
Guernsey
Colombia
Armenia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Morocco
Seychelles
Botswana
Paraguay
Canada
South Africa
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
Ireland
India
Germany
United States
Indonesia
Middle East
Dominican Republic
Asia
Bermuda
Spain
Albania
Argentina
Europe
Bangladesh
Qatar
Barbados
Angola
Belgium
Cyprus
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Ecuador
Faroe Islands
Jersey
Bahrain
Estonia
Bolivia
Bahamas
Belize
Algeria
Italy
Belarus
Finland
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Slovenia
Mongolia
Peru
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Hemi Ventures, VC Fund

Hemi Ventures

VC Fund

Palo Alto, United States

Hemi Ventures is a VC fund in Palo Alto focused on Health Care and Artificial Intelligence. Hemi Ventures invests in early stage startups in autonomous vehicles, artificial intelligence applications, biotech, and other emerging technology sectors. We partner with entrepreneurs whose cutting edge innovations unlock new frontiers for human potential. ‘Hemi’ (hēmi-) means ‘half’ in Greek. We serve as a complementary half to our founders. Inaddition to capital, we help founders establish pivotal relationships with industry partners and customers to build strong ecosystems that help them grow.

Total investments:
34
Last investment:
Lead investor:
18%
Last fund:

Last updated:

Industries Hemi Ventures invests in

Health CareArtificial IntelligenceAutomotiveBiotechnologyAutonomous Vehicles

Stages Hemi Ventures invests in

SeedSeries AFunding RoundVenture - Series UnknownPre-Seed

Countries Hemi Ventures invests in

United StatesChinaSouth Korea

Round sizes

Seed $500k–$6MSeries A $2M–$31M

Contacts

NameEmailPhoneSocials

Sign up to unlock verified contacts

Unlock Contacts

Round size

Seed
$500k–$6M
Series A
$2M–$31M

Investment Focus

Industry

  • Health Care 7 (21%)
  • Artificial Intelligence 7 (21%)
  • Automotive 6 (18%)
  • Biotechnology 6 (18%)
  • Autonomous Vehicles 5 (15%)
See all 48 industries →

Stage

  • Seed 16 (47%)
  • Series A 11 (32%)
  • Funding Round 2 (6%)
  • Venture - Series Unknown 2 (6%)
  • Pre-Seed 1 (3%)
See all 6 stages →

Country

  • United States 22 (65%)
  • China 1 (3%)
  • South Korea 1 (3%)

Team

NameTitleInvestmentsLinksEmail
Amy Gu
Amy Gu Founder and Managing Partner
Founder and Managing Partner Total investments: 6
Find email
Justin Li
Justin Li Principal
Principal Total investments: 0
Find email

Investments

CompanyDescriptionRoundLinks
Novauto develops an intelligent computing platform for smart driving. Series A / May 14, 2020
Phase Genomics' mission is to help scientists make breakthrough discoveries by providing the most complete, accurate, detailed genomes and metagenomes available from any technology. Venture - Series Unknown / Feb 26, 2020
Ravel Biotechnology markets an analytic technology platform capable of early detection of disease from cell-free DNA.The technology platform enables the accelerated development and validation of screening tests for a wide range of diseases from a single analyte, cell-free DNA. Thus providing the opportunity to screen for a multitude of diseasesfrom a single blood draw.The company was co-founded by Erik Gafni and Nathan Boley in 2018 and is based in San Francisco, California. Jan 01, 2020
Elaborate the cutting edge electronic technology and the most advanced medical science to equip the clinicians Series A / Dec 09, 2019
X-37 is a pharmaceutical discovery and development company, which uses advanced artificial intelligence technology from Atomwise, Inc. to discover novel drug candidates by screening vast libraries of chemical compounds against high-value pharmaceutical targets. $14.5M / Series A / Nov 14, 2019
Smart Radar System (SRS) is a pioneer in the field of 4D image radar. Having specialized in radar technology for more than three years, SRS is developing the world's first 4D image radar, RETINA, with sub 1 degree angular resolution and 360 degree surround view. $4M / Series A / Oct 28, 2019
MetaMe Health is currently developing Regulora™ for IBS to become the first FDA-cleared prescription-only digital therapeutic for the treatment of Irritable Bowel Syndrome (IBS). More than 30 million Americans are affected by IBS, and the abdominal pain, diarrhea, and/or constipation that comes with it. Regulora™ for IBS provides relief bydigitizing a standardized Brain-Gut therapy approach that has been clinically proven to be effective in reducing IBS symptoms. Seed / Aug 05, 2019
Tensorflight provides detailed, accurate, and near-instant commercial property data. Our engine based on machine learning, AI, and computer vision analyzes images of the whole structure in order to build a database of all buildings in the world, providing features such as:- Building footprint and square footage- AI-based replacement cost-Number of stories- Construction type- Roof attributes like geometry or material- And much more $2M / Series A / Jul 17, 2019
Tensorflight provides detailed, accurate, and near-instant commercial property data. Our engine based on machine learning, AI, and computer vision analyzes images of the whole structure in order to build a database of all buildings in the world, providing features such as:- Building footprint and square footage- AI-based replacement cost-Number of stories- Construction type- Roof attributes like geometry or material- And much more $2M / Seed / Jun 21, 2019
NAVAN Technologies, Inc., (NAVAN) is a pre-clinical stage biotechnology company developing and commercializing its proprietary NanoStraw platform technology, which establishes a direct, physical connection into cells to overcome a huge challenge faced by researchers globally: delivering material into hard-to-transfect-cells in an efficient yetgentle and non-perturbative manne Seed / Apr 25, 2019
See all 34 investments →

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Cryptocurrency
Oil and Gas
Film
Retail
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
B2B
Blockchain
Social Network
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Art
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Recruiting
Web3
Medical
Theatre
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
South Korea
Benin
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Japan
Poland
Oman
Puerto Rico
Cameroon
Guernsey
Colombia
Armenia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Morocco
Seychelles
Botswana
Paraguay
Canada
South Africa
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
Ireland
India
Germany
United States
Indonesia
Middle East
Dominican Republic
Asia
Bermuda
Spain
Albania
Argentina
Europe
Bangladesh
Qatar
Barbados
Angola
Belgium
Cyprus
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Ecuador
Faroe Islands
Jersey
Bahrain
Estonia
Bolivia
Bahamas
Belize
Algeria
Italy
Belarus
Finland
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Slovenia
Mongolia
Peru
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Hemi Ventures invest in?

Hemi Ventures invests primarily in Health Care, Artificial Intelligence and Automotive startups, most often at Seed and Series A stage. Most of the 34 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What is Hemi Ventures's check size?

Hemi Ventures typically joins rounds of $500k–$6M at Seed and $2M–$31M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Hemi Ventures participates in.

How do I contact Hemi Ventures?

Public channels for Hemi Ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Hemi Ventures?

The team at Hemi Ventures includes Amy Gu (Founder and Managing Partner) and Justin Li (Principal). The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Hemi Ventures Hemi Ventures Find emails